Skip to Content
MarketWatch

Tesla stock falls again after downbeat China sales data

Tomi Kilgore

April electric vehicle sales in China fall from March, with Tesla's performance worse than its peers; Nio, Xpeng and Li Auto stocks also slump

Shares of Tesla Inc. fell again Tuesday, after the electric vehicle maker's April sales in China fell sharply from March, more so than its rivals amid negative public relations issues.

The stock (TSLA) declined 1.6% in afternoon trading, but pared earlier intraday losses of as much as 5.3%. The selloff adds to the 6.4% drop on Monday, which followed a three-week losing streak in which the shares shed 9.1%.

Tesla sold 25,845 vehicles made in China in April (link). Although that was up from January sales of 15,484 vehicles and February sales of 18,318 vehicles, according to data provided by Wedbush analyst Dan Ives, April sales were down 27% from March.

Overall April electric vehicle sales in China fell 12% from March. Among China-based EV makers, shares of Nio Inc. (NIO) swung to a gain of 1.9%, reversing an earlier loss of as much as 6.2%; Xpeng Inc. (XPEV) shed 2.8% toward a six-month low; and Li Auto Inc. (LI) slipped 0.1% toward a seven-month low.

"Tesla's share gains stagnated vs. domestic players Nio, Xpeng and Li Auto during the month as the company faced a handful of negative PR issues in China (link) stemming from well discussed safety issues, military spy noise and the protest at the Shanghai Auto Expo," Ives wrote in a note to clients.

The protest refers to an incident last week, when a protester climbed on top of a Tesla car (link) and shouted allegations about faulty brakes.

"[C]learly, Musk & Co. need to play nice in the sandbox with Beijing and smooth out the PR issues in the region which have been a black eye for Tesla over the last month and clearly impacted China sales negatively in the month of April, which the Street will react with a selloff in shares [Tuesday] morning," Ives wrote.

Separately, Reuters reported Tuesday that Tesla has halted a plan to buy land in Shanghai (link) to expand its manufacturing in China, given trade tensions between China and the U.S.

Besides the PR issues in China, Ives said Tesla is also facing a chip shortage (link) issue, which is putting more pressure on production and transportation to fulfill global demand.

After rocketing 743.4% in 2020, Tesla's stock has dropped 12.3% year to date, while the S&P 500 index has gained 10.6% this year.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

 

(END) Dow Jones Newswires

05-11-21 1504ET

Copyright (c) 2021 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.